FDA campus project
General Services Administration has received "quite a few" offers in response to a request for bids for a Montgomery County, Md. site for FDA facilities, part of the effort to consolidate all Washington, D.C.-area FDA buildings into a two-site campus ("The Pink Sheet" Dec. 21, 1992, In Brief). The selection of a preferred candidate site will take about a year.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth